... Platelet Disorder Support Association Off-Label Rituximab Proves Its Mettle in Adult ITP — ASH Clinical News B-Cell Lymphocyte Depletion Therapy — Platelet Disorder Support Association Chemotherapy — Platelet Disorder Support Association Thrombopoietin Receptor Agonists in Primary ITP — Seminars in Hematology Fostamatinib — Drugs.com FDA Approves Wayrilz ...
How To Treat ITP: 13 Treatment Options and How They Work
... Platelet Disorder Support Association Off-Label Rituximab Proves Its Mettle in Adult ITP — ASH Clinical News B-Cell Lymphocyte Depletion Therapy — Platelet Disorder Support Association Chemotherapy — Platelet Disorder Support Association Thrombopoietin Receptor Agonists in Primary ITP — Seminars in Hematology Fostamatinib — Drugs.com FDA Approves Wayrilz ...
... By blocking BTK, these medicines reduce B-cell activity and help protect your platelets.The first and only BTK inhibitor currently FDA-approved for chronic ITP is rilzabrutinib (Wayrilz). This medicine is taken by mouth and is being tested further in international clinical trials. ...
5 New Treatments for Chronic ITP
... By blocking BTK, these medicines reduce B-cell activity and help protect your platelets.The first and only BTK inhibitor currently FDA-approved for chronic ITP is rilzabrutinib (Wayrilz). This medicine is taken by mouth and is being tested further in international clinical trials. ...
... Second-line treatment Rilzabrutinib (Wayrilz) This Bruton’s tyrosine kinase inhibitor is approved for adults with chronic ITP who have had an inadequate response to previous treatment. ...
Immune Thrombocytopenia: 7 Facts To Know
... Second-line treatment Rilzabrutinib (Wayrilz) This Bruton’s tyrosine kinase inhibitor is approved for adults with chronic ITP who have had an inadequate response to previous treatment. ...